Latest Market Development News

Page 2 of 17
Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.
Ada Torres
Ada Torres
31 Aug 2026
Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.
Ada Torres
Ada Torres
31 Aug 2026
Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.
Ada Torres
Ada Torres
28 Aug 2026
Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.
Victor Sage
Victor Sage
20 Aug 2026
NZX Limited reported a robust first half of 2026 with operating earnings up 9.4% and net profit rising 18%. The exchange strengthened its funds management and wealth administration arms, relaunched equity derivatives, and declared a higher interim dividend. A new CEO is set to take the helm in September.
Claire Turing
Claire Turing
20 Aug 2026
EAU Lithium, a subsidiary of Cosmos Exploration, has signed a strategic Master Services Agreement with VULTEC, the German technology arm of Vulcan Energy Resources, to advance lithium extraction projects in Bolivia using cutting-edge direct lithium extraction technology.
Maxwell Dee
Maxwell Dee
13 Aug 2026
Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.
Ada Torres
Ada Torres
30 July 2026
Lunnon Metals boosts cash to $22.2 million as Lady Herial mining wraps up, launching a record $13 million exploration budget targeting up to 2.4 million ounces of gold at Foster-Baker.
Maxwell Dee
Maxwell Dee
30 July 2026
Saluda Medical capped FY26 with a 28% revenue surge, beating guidance at US$90.2 million, while FDA approval for its CAP24 paddle lead opens a new US surgical market segment.
Ada Torres
Ada Torres
29 July 2026
Canadian Phosphate has secured a five-year exploration permit for its Wapiti Phosphate Project and commenced a 3,000m drilling campaign, while progressing the pending acquisition of the Diamond Mountain Project in Utah. A $5.2 million capital raise positions the company to accelerate its North American phosphate ambitions.
Maxwell Dee
Maxwell Dee
29 July 2026
IKE GPS delivered a 31% jump in subscription revenue exit run rate in 1Q FY27, with three new products and an AI platform set to fuel further growth in the second half.
Sophie Babbage
Sophie Babbage
29 July 2026
ReadCloud Limited’s June quarter saw a record $3.5m in cash receipts from its school businesses, driving 6% year-to-date growth despite exiting its Industry Training arm. The company forecasts over $1m uEBITDA for FY26 and is building momentum for FY27 expansion.
Victor Sage
Victor Sage
28 July 2026

Browse the archive

Full archive